Daiichi Sankyo Company, Limited

4568.T
Drug Manufacturers - General
2026/08/23 Updated
Market Cap: $32.4B (¥5.2T)
Stock Price: $17.82 (¥2,834)
Exchange Rate: 1 USD = ¥158.98

(Correction) Regarding Partially Corrected “Financial Summary for FY2025”

Announces a correction to a part of the FY2025 financial summary. Recognized an additional liability of 31.6 billion yen directly related to assets held for sale, related to current liabilities.

Importance:
Page Updated: May 13, 2026
IR Disclosure Date: May 13, 2026

Key Figures

  • Total current liabilities (as of March 2026): 885.0 billion yen (after correction)
  • Liabilities directly related to assets held for sale: 31.6 billion yen (newly recorded)
  • Total liabilities and equity (as of March 2026): 4,005.4 billion yen

AI要約

Summary of the Correction

Daiichi Sankyo Company, Limited corrected some errors in the 'Financial Summary for FY2025' announced on May 11, 2026. The main correction involves recording an additional 31.6 billion yen in liabilities related to assets held for sale within current liabilities. As a result, the subtotal of current liabilities was adjusted from 754.0 billion yen to 853.5 billion yen. There were no changes to other liabilities and equity figures, and the financial statement itself remains uncorrected.

Impact on Investors and Future Response

This correction pertains to adjustments in some supplementary material figures and does not affect the contents of the financial summary, so there is no material impact on performance. Investors can verify the corrected materials on the official website, ensuring transparency. The company continues to commit to accurate disclosure and maintaining trust.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Daiichi Sankyo Company, Limited

Company overview · Stock price · Financial data · All IR

View company page →